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Post-translational modifications (PTMs) of histones play an
important role inmanycellularprocesses, notably gene regulation.
Using a combination of mass spectrometric and immunobio-
chemical approaches, we show that the PTMprofile of histoneH3
differs significantlyamongthevariousmodelorganismsexamined.
Unicellular eukaryotes, such as Saccharomyces cerevisiae (yeast)
and Tetrahymena thermophila (Tet), for example, contain more
activationthansilencingmarksascomparedwithmammaliancells
(mouse and human), which are generally enriched in PTMs more
often associated with gene silencing. Close examination reveals
thatmany of the better-knownmodified lysines (Lys) can be either
methylatedoracetylatedandthat theoverallmodificationpatterns
become more complex from unicellular eukaryotes to mammals.
Additionally,novel species-specificH3PTMsfromwild-typeasyn-
chronously grown cells are also detected by mass spectrometry.
Our results suggest that somePTMs aremore conserved than pre-
viously thought, includingH3K9me1 andH4K20me2 in yeast and
H3K27me1, -me2, and -me3 inTet.OnhistoneH4,methylation at
Lys-20 showed a similar pattern as H3 methylation at Lys-9, with
mammals containingmoremethylation than the unicellular orga-
nisms. Additionally, modification profiles of H4 acetylation were
very similar among the organisms examined.
Cellular identity is defined by the characteristic patterns
of gene expression and silencing. Inheritance of these tran-
scription patterns through DNA replication and chromatin
assembly that accompanies each cell division is crucial for
cell survival, but the one or more mechanisms by which this
“memory” is achieved are not well understood (reviewed in
Ref. 1). A rapidly emerging literature suggests that histone
proteins, which function to package genomic DNA into
repeating nucleosomal units that are then further folded into
higher order chromatin fibers, may be major carriers of epi-
genetic information (2). Each nucleosome typically contains
146 bp of DNA wrapped around two copies each of his-
tones H3, H4, H2A, and H2B. Although providing a relative
constant packaging theme, subtle changes in nucleosome
histone:DNA and histone:histone contacts are likely to pro-
vide variation in fiber folding that, in turn, translates into
biological readout.
In general, the packaging of DNA into chromatin is recog-
nized to be a major mechanism by which the access of genomic
DNA is restricted. This physical barrier to the underlying DNA
is precisely regulated (and counteracted), at least in part, by the
post-translational modifications (PTMs)9 of histones. A wide
number of studies has revealed that PTMs of histones, espe-
cially those located in the N-terminal tails, play a pivotal role in
the regulation of chromatin structure necessary forDNAacces-
sibility during gene expression. Remarkable diversity in the his-
tone/nucleosome structure is generated by a variety of PTMs,
such as lysine and arginine methylation, lysine acetylation, ser-
ine and threonine phosphorylation, and lysine ubiquitination
(reviewed in Refs. 3–5). Some PTMs, including acetylation and
phosphorylation, are reversible and dynamic and are often
associated with inducible gene expression. Other PTMs, such
as lysine methylation, are often found to bemore stable, partic-
ipating in long term maintenance of the expression status of
regions in the genome that vary in certain developmental con-
texts (6). Nevertheless, recent work has shown thatmany lysine
methylation “marks” on histones can also be reversed by enzy-
matic means (7–9).
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Histone PTMs occur on multiple but specific sites, suggest-
ing that histone PTMs can act as signaling platforms for pro-
teins that “read” these marks (10). The “histone-code hypothe-
sis” has beenput forward to explain howdifferent combinations
of histone PTMs can result in distinct chromatin-regulated
functions (11–13). The deciphering of the “code” is compli-
cated further by the observation that certain residues can be
either acetylated or methylated, as has been shown for histone
H3 lysine 9 in mammalian cells (14). Acetylation of these resi-
dues is associated with transcriptional activation and methyla-
tion often, but not always (see below), with repression of genes.
In contrast, methylation of histone H3 on Lys-4, Lys-36, and
Lys-79 correlates with transcriptional activation of genes (15–
17). Besides PTMs, the exchange of core histones with histone
variants, which differ slightly in their amino acid sequence and
which are enriched in different marks (18, 19), adds additional
complexity to the structure and function of chromatin.
In this study, we sought to examine the extent to which the
histone code is universal, focusing onH3 andH4 froma limited,
but select, number of popular organisms as an entry point for
our studies. Using both mass spectrometry (MS) and immuno-
biochemical approaches, we show that the PTM profile of his-
toneH3 greatly differs among species and that the PTMpattern
is more complex in mammals as compared with “simple”
eukaryotes, such as Saccharomyces cerevisiae (yeast) andTetra-
hymena thermophila (Tet). Unicellular eukaryotes exhibit
more marks associated with transcriptional activation or tran-
scriptional competency, whereasmammals containmoremod-
ifications linked to gene repression. Additionally, we identified
several novel PTMs that are potentially species-specific, such as
H3K4ac (observed in Tet, mouse, and human) and H3K79ac
(human), H3K23me1 (yeast, mouse, and human), H3K14me2
and H3K64ac (yeast), and H3K56me3 (human). Surprisingly,
we observed low amounts of H3K9me1 and H3K27me3 in
yeast, and H3K27me1, -me2, and -me3 in Tet; such modifi-
cations have not been detected before in these particular
organisms.
Additionally, we characterized PTMs of histone H4 from the
same set of organisms. We found that H4 is far less modified
thanH3 and that theH4 acetylation patterns remained consist-
ent across the species examined. In addition, H4K20 methyla-
tion was found in higher levels on human and mouse than the
unicellular species. Some low abundance novel H4 PTMs were
also identified, such as H4K20me2 and H4K20ac in yeast. Col-
lectively, our data reveal a diverse pattern ofmodification usage
on histone H3 that is fundamentally different among unicellu-
lar organisms and mammals. We suggest that these differences
may be due to the co-development of additional histone-mod-
ifying enzymes and histone H3 variants, allowing for additional
regulation of more complex genomes.
EXPERIMENTAL PROCEDURES
Cell Cultures—HeLa, HEK293, NIH3T3, and MEF cell lines
were grown in Iscove’s Dulbecco’s modified Eagle’s medium
supplemented with 10% fetal calf serum and penicillin/strepto-
mycin at 37 °C and 5% CO2. Insect S2 cells were grown in
Iscove’s insect medium (Invitrogen) supplemented with 10%
fetal calf serum at 27 °C.T. thermophila and S. cerevisiae (strain
BY4741) were grown as described previously (20, 21). Spleno-
cytes from MRL-MPJ mice were also prepared as previously
described (22).
Histone Extraction—Nuclei and histones from mamma-
lian and Drosophila cells were isolated as described earlier
(19). T. thermophila and yeast histones were isolated as
described previously (20, 21).
RP-HPLC—Separation of human and mouse core histones
by RP-HPLC was performed as described previously (19).
RP-HPLC fractions were resuspended in water, a fraction was
analyzed by SDS-PAGE and stained with Coomassie Brilliant
Blue as control, and the liquid samples were subjected to MS
analysis. Similar gradients were used for T. thermophila and
yeast histones (20, 21).
Histone Sample Preparation—Histones H3 and H4 were
treated with propionylation reagent, digested with trypsin, and
re-propionylated as previously described (23).
MS—Propionylated histone digest mixtures were loaded
onto capillary precolumns and analyzed essentially as previ-
ously reported (24). Briefly, all samples were analyzed by nano-
flow HPLC-microelectrospray ionization MS/MS (24) on a
Finnigan linear quadrupole ion trap-Fourier transform ion
cyclotron resonancemass spectrometer (Thermo Electron, San
Jose, CA) operated in data-dependent mode. The HPLC gradi-
ent used on an Agilent 1100 series HPLC solvent delivery sys-
tem (Palo Alto, CA) consisted of 0–60% B in 60 min, and then
60–100% B in 10 min (A  0.1% acetic acid, B  70% acetoni-
trile in 0.1% acetic acid).
Immunoblotting—Immunoblots with total acid extracted
histones were done as described previously (25). For peptide
competition, the H3K4 acetyl antibody was incubated for 1 h at
4 °C with 1 g/ml of the following peptides: H3 unmodified,
amino acids 1–20; H3K4ac, amino acids 1–20 with Lys-4 acety-
lated; H3K4me2; amino acids 1–20 with Lys-4 dimethylated;
H3K9ac, amino acids 1–20 with Lys-9 acetylated; H3K36ac,
amino acids 27–46 with Lys-36 acetylated; H4 unmodified,
amino acids 1–16; H4K5ac, amino acids 2–20 with Lys-5 acety-
lated; and H4 tetra-acetyl, amino acids 1–18 with Lys-5, Lys-8,
Lys-12, and Lys-16 acetylated. Peptides were synthesized and
verified byMS at the Proteomics Resource Center of The Rock-
efeller University, Upstate Biotechnology, and the Protein
Chemistry Core Facility at the University of North Carolina,
School of Medicine.
Enzyme-linked Immunosorbent Assay—The same peptides
used in peptide competition assays were also used for the
enzyme-linked immunosorbent assay. Briefly, peptides were
diluted in phosphate-buffered saline in concentrations from 0
to 100 ng/ml, and 200 l was transferred to a 96-well plate
(Covance) and incubated overnight at 37 °C. The plate was
washed twice with phosphate-buffered saline (containing
0.05% Tween 20), blocked with 200 l of phosphate-buffered
saline/0.05% Tween 20 containing 1% bovine serum albumin,
and incubated at 37 °C for 1 h. After two additional wash steps,
100 l of diluted primary antibody was added to the plate, and
the mixture was incubated for 2 h at 37 °C. After washing, 100
l of secondary horseradish peroxidase-conjugated antibody
was added, and themixturewas incubated for 2 h at 37 °C. After
two wash steps 100 l ofO-phenylenediamine dihydrochloride
Histone Modification Differences among Organisms
7642 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 282 • NUMBER 10 • MARCH 9, 2007
substrate (Sigma) was added, and the plate was incubated at
room temperature in the dark for 30 min. The detection reac-
tion was stopped with 100 l of 3 M HCl, and the absorbance
was measured at 492 nm in a plate reader (Bioscan).
Antibodies—To develop an antibody against histone
H3K4ac, a synthetic histoneH3peptidemodified by acetylation
at Lys-4 was chemically synthesized, conjugated to KLH, and
used to immunize rabbits by Upstate Biotechnology. The posi-
tive anti-sera were further purified by immunoaffinity purifica-
tion. TheH3K4ac antibodywas diluted 1:1,000 in immunoblots
and enzyme-linked immunosorbent assay and 1:100 in immu-
nofluorescence microscopy. The following antibodies from
Upstate Biotechnology were used as 1:1,000 dilutions in immu-
noblots: H3K9me1, -me2, and -me3; H3K27me1, -me2, -me3,
and -ac; H3K36me1 and -me2; andH3K79me2.One other anti-
serum fromUBI was used in this study in the following dilution
in immunoblot: H3K56ac (1:5,000), and the following antibod-
ies from Abcam were used: H3K4me1, -me2, and -me3
(1:1,000) and H3K79me3 (1:1,000). The anti-H3K36me3 anti-
body, obtained from UBI, was used at a 1:10,000 dilution.
Immunofluorescence Microscopy—Immunofluorescence mi-
croscopy analyses were done as described previously (25).
RESULTS
Comparison of Histone H3 PTMs among Unicellular
Eukaryotes and Mammals—To examine the PTM profiles on
histone H3 from different species, we extracted and RP-HPLC-
purified histones from several model organisms, including
yeast, Tet, mouse, and human cells. All of the RP-HPLC
H3-containing fractions (regardless of which H3 variants were
present, see supplemental Fig. S1) were combined and then
subjected to tandem mass spectrometry (MS/MS), which has
been successfully used previously to analyze histone H3 (19).
This procedure results in the production of predicted peptide
sets that could be easily detected by MS (19).
Species Comparison of “ON” Marks—Shown in Fig. 1 are
mass spectra that facilitate a comparative analysis of PTMs that
occur at lysine 4 of H3, a well known “ON” epigenetic methyl-
ation mark (26). Summed mass spectra that record the ion
abundances for [M  2H]2 ions corresponding to residues
3–8 of H3 from human, mouse, Tet, and yeast are presented in
Fig. 1, A–D, respectively. Because the protein samples have
been derivatizedwith propionic anhydride (addition of 56Da to
unmodified andmonomethylated lysine residues, only) prior to
enzymatic digestion with trypsin, the signals for the [M 
2H]2 ions of peptides containing H3K4me2, H3K4me3,
H3K4, and H3K4me1 appeared at m/z 394, 401, 408, and 415,
respectively.
As indicated in Fig. 1 (A–D), the degree of methylation of
Lys-4 among the various organisms examined greatly differs
with several consistent trends noted. As shown in Fig. 1 (A and
B), human and mouse H3 display similar profiles: unmodified
Lys-4 is themost abundant species, whereas K4me1 is very low.
Occasionally, contaminant peaks were observed in the mass
spectra that, upon fragmentation, produce MS/MS spectra,
which do not match any histone peptide such as the singly
charged ion aroundm/z 396.8 (Fig. 1B, asterisk). Surprisingly, a
small amount of K4ac was seen in human H3 (Fig. 1A and sup-
plemental Figs. S2 and S3), as differentiated by accurate mass
(0.25 ppm) and retention time. Accurate mass measurement
with the linear quadrupole ion trap-Fourier transform instru-
ment can distinguish between trimethylated and acetylated
peptides (m 0.0364Da). To our knowledge, H3K4ac has not
been reported in histones from any source. We also detected
this novel modification as existing in a lower abundance in Tet
and mouse, but this mark was not observed with our current
detection limits in yeast.
In striking contrast, however, we found that unicellular
eukaryotes (Tet and yeast) contained higher degrees of
H3K4me1, -me2, and -me3. Unlike in human and mouse H3;
Tet (Fig. 1C) and yeast (Fig. 1D) H3 display clearly visible
amounts of K4me2 and -me3. These results agree well with
immunoblot analyses showing a large amount of H3K4me2
detected on histoneH3 from ciliate and yeast as comparedwith
mouse and human histone (27), as well as robust enzymatic
Lys-4 methylation activity found in crude preparations of yeast
and ciliate nuclei (28). The degree of methylation on H3K4 is
easily differentiated by tandem MS. For example, an MS/MS
spectrum of the [M  2H]2 peptide at 394.7344m/z from the
Tet sample (Fig. 1C) is shown in Fig. 1E, and the b1, b2, y4, and y5
fragment ions indicate that H3K4 is dimethylated on this pep-
tide (3–8 residues). Fig. 1F shows an MS/MS spectrum of the
doubly charged peptide ion at 401.7425m/z generated from the
yeast H3 sample (Fig. 1D) and was identified as the 3–8 residue
fragment containing K4me3 as revealed by the y4 and y5 frag-
ment ions. The experimental mass of this peptide is consistent
with trimethylation (1.1 ppm error) and not acetylation
(44.1 ppm error). These data show that mammals have far
less H3K4 methylation than unicellular eukaryotes, suggest-
ing that the usage of this particular ON mark was reduced
during evolution.
Anothermodification associated with transcriptional activa-
tion is the methylation of H3K79 by the Dot1 histone methyl-
transferase (29). A comparison of PTMs on a peptide spanning
residues 73–83 of histone H3 that contains the Lys-79 residue
from the above mentioned four different species can be seen in
Fig. 2 The PTM profiles at this site are remarkably different
than what we observed on peptides containing H3K4. For
example, human and mouse H3 (Fig. 2, A and B) displayed
similar profiles (H3K79me1 is the most abundant species) and
H3K79me2 was also observed. Interestingly, a small amount of
H3K79ac could be seen as differentiated by accurate mass
(3.2 ppm) on the human sample (see also supplemental data
page 6). Nevertheless, the degree of methylation of H3K79 was
restricted to only a small amount of monomethylation in Tet
(Fig. 2C), whereas yeast contained a high degree of H3K79
methylation with the trimethylated form being the most abun-
dant (Fig. 2D). A tandem mass spectrum of the [M  2H]2
peptide at 727.8863 m/z from the Tet sample is shown in Fig.
2E, and fragment ions (b6, b7, y4, and y5) indicate that H3K79 is
monomethylated on this peptide (73–83 residues). Fig. 2F
shows an MS/MS spectrum of the doubly charged ion at
717.3864 m/z generated from the yeast H3 sample (Fig. 2D).
This peptide was identified as the 73–83 residue fragment con-
taining H3K79me3 as determined from observing the same
indicator fragment ions (b6, b7, y4, and y5) as seen on Fig. 2E.
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FIGURE 1. Comparison of full mass spectra depicting H3K4 modifications on the [M  2H]2 peptide spanning residues 3– 8 TKQTAR from human HEK
cells (A), mouse MEF cells (B), Tet (C), and yeast (D). E, MS/MS spectrum of the [M  2H]2 3– 8 peptide containing H3K4me2 from the Tet sample. A propionyl
group (pr) is present on the N terminus. F, MS/MS spectrum of the [M  2H]2 3– 8 peptide containing H3K4me3 from the yeast sample. A propionyl group (pr)
is present on the N terminus. b and y type ions are labeled in E and F. Ions arising from non-histone peptides or contamination are labeled with an asterisk.
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FIGURE 2. Comparison of full mass spectra depicting H3K79 modifications on the [M  2H]2 peptide spanning residues 73– 83 (EIAQDFKTDLR) from
human HEK cells (A), mouse MEF cells (B), Tet (DIAHEFKAELR) (C), and yeast (D). E, MS/MS spectrum of the [M  2H]2 73– 83 peptide containing
H3K79me1 from the Tet sample. A propionyl group (pr) is present on the N terminus. F, MS/MS spectrum of the [M  2H]2 73– 83 peptide containing
H3K79me3 from yeast. A propionyl group (pr) is present on the N terminus. b and y type ions are labeled in E and F.
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The experimental mass of this peptide (717.3864 m/z) deter-
mined that a trimethylation (1.1 ppm error) and not acetyla-
tion (26.5 ppm error) mark was present.
These data suggest that, similar to the H3K4 modification
profile, mouse and human are almost identical in their H3K79
modifications. On the other hand, in contrast to H3K4 methy-
lation, yeast and Tet are different from each other in their PTM
profile, possibly due to the lack of Dot1 and sequence differ-
ences in Tet. In conclusion, mammals are similar to each other,
but differ greatly from unicellular eukaryotes with regard to
their H3K4 and Lys-79 modification profiles.
Species Comparison of OFFMarks—Awell established mod-
ification that is associated with transcriptional repression and
constitutive heterochromatin formation is the methylation of
H3K9 (30). We wondered if organisms differ in their H3K9
modification profile from each other, as we have seen for ON
marks (Figs. 1 and 2). A species comparison of modifications at
Lys-9 on histone H3 is shown in Fig. 3, a residue known to
exhibit both acetylation (ON) or methylation (OFF). Fig. 3
shows the summed full mass spectra around the 520–550 m/z
range, which display the [M  2H]2 peptides spanning resi-
dues 9–17 from human (A), mouse (B), Tet (C), and yeast (D)
samples. In contrast to the modification profiles obtained on
H3K4 from the same species, an increasing shift in the degree of
methylation at H3K9 was seen in mammals as compared with
Tet and yeast. Both human and mouse contain H3K9, -me1,
-me2, -me3, and -ac, with H3K9me2 being the most abundant
modification.
Peptides containing Lys-9 from Tet and yeast H3 (Fig. 3, C
andD) show that this residue is not as heavilymodified, because
the unmodified peptide is the most abundant species in both
organisms. Acetylated peptides account for the most abundant
modification in both unicellular organisms, withH3K9ac inTet
being present at relatively higher levels (Fig. 3C). Unexpectedly,
based on the existing literature, a low amount of H3K9me3 is
detected inTet, andH3K9me1 (see also supplemental data page
3) in yeast to far less of an extent and degree of methylation at
Lys-9 that characterizesmammals. Localization of themodified
site was accomplished by MS/MS, and Fig. 3E depicts an
MS/MS spectrum of the [M  2H]2 9–17 residue peptide at
535.3129 m/z from the Tet sample. Fragment ion b1 indicates
the presence of H3K9me3. A tandem mass spectrum is dis-
played in Fig. 3F of the [M  2H]2 9–17 residue peptide at
521.3056m/z generated from the human sample, and the b1 ion
determined that it contained H3K9me2.
These data suggest that, as observed for ON modifications,
the H3K9 modification profiles of mammals are almost identi-
cal to each other but differ greatly from the ones detected in
unicellular eukaryotes. In contrast to the ONmarks, which are
present in very low abundance in human and mouse, OFF
marks are easily detectable in more complex organisms,
whereas the opposite is true for unicellular eukaryotes.
Lastly, we examined the modification profile of H3 peptides
spanning residues 27–40, which contain both Lys-27 and Lys-
36, two well known modification sites that when methylated
have been linked to gene repression and activation, respectively
(16, 31). Shown in Fig. 4 are mass spectra that facilitate a com-
parative analysis of modifications that occur on Lys-27 and
Lys-36 of H3. Summed mass spectra, which record the ion
abundances for [M  2H]2 ions corresponding to residues
27–40 of H3 from human, mouse, Tet, and yeast, are presented
in panels A–D, respectively. In samples fromhuman andmouse
cells, we found several different isomeric forms of H3. Of the
H3 isomeric forms detected in mammals the one acetylated at
Lys-27 was by far the least abundant. Isomeric forms without
modifications on Lys-27 and Lys-36 and those that contain
K27me1, K27me2, K36me1, and K36me2 andmodifications on
both Lys-27 and Lys-36 were of intermediate abundance. H3
with K27me3 was the most abundant isomeric form in the
mixture.
Fig. 4 (C andD) shows themass spectral data acquired onH3
isomeric forms isolated from Tet and yeast. We found these
samples were enriched in H3 not modified at either Lys-27 or
Lys-36. Both samples were also enriched for the isomeric form
containing K27ac. Isomeric forms that contained K27me1,
K27me2, and K27me3 were abundant in Tet but not readily
detected in yeast. The finding ofmethylatedH3 Lys-27 in Tet is
novel and is currently under investigation.10 Isomeric forms
that contain K36me1, -me2, and -me3 were abundant in yeast,
but only K36me1 could be detected in Tet. Evidence for
H3K36ac was found in both Tet and yeast samples, albeit at low
levels, and the function of this particular newmark is currently
under investigation (see companion report (52)).
Although several peptides containing the same nominal
masses spanning residues 27–40 were observed, their slightly
different elution profiles allow for MS/MS spectra to be
recorded from these unique species thus unambiguously iden-
tifying themodified site, allowing for PTMassignment to either
H3K27 or H3K36. For example, Fig. 4E shows anMS/MS spec-
trum of the doubly charged ion atm/z 830.4792 from the yeast
sample, and the fragment ions b9, b10, y4, and y5 identify Lys-36
as a trimethylation site. The b1 ion, however, was used to iden-
tify the trimethylation site on Lys-27 from the MS/MS spec-
trum of the human sample (Fig. 4F). We have also included
several representative MS/MS spectra, which demonstrate the
ability of our MS platform to distinguish peptides with modifi-
cations at either H3K27 or H3K36, as supplemental data pages
7–24.
In sum, Tet primarily utilizes H3K27 methylation, whereas
yeast mostly uses H3K36methylation. Additionally, unicellular
eukaryotes also do not display the complex array of peptides
consisting of different combination of concurrent modifica-
tions at H3K27 and H3K36 as do mammals.
Table 1 provides a summary of all covalent modifications
detected on H3 from yeast, Tet, mouse, and human cells. Our
analyses show a remarkably large number of differences in the
usage of covalent modifications among species (  easily
detected in both experiments, ND  not detected, L 
detected in low abundance, and V  detected in only one
experiment).
Immunobiochemical Analysis of Abundant H3 PTMs—We
first analyzed the MS data for the presence of very abundant
10 Taverna, S. D., Ueberheide, B. M., Lin, Y., Tackett, A. J., Diaz, R. L., Shabanowitz, J.,
Chait, B. T., Hunt, D. F., and Allis, C. D. (2007) Proc. Natl. Acad. Sci. U.S.A.,
in press.
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FIGURE 3. Comparison of full mass spectra depicting H3K9 modifications on the [M  2H]2 peptide spanning residues 9 –17 KSTGGKAPR from human
HEK cells (A), mouse MEF cells (B), Tet (KSTGAKAPR) (C), and yeast (D). E, MS/MS spectrum of the [M  2H]2 9 –17 peptide containing H3K9me3 from the
Tet sample. Propionyl groups (pr) are present on the N terminus and on Lys-14. F, MS/MS spectrum of the [M  2H]2 9 –17 peptide containing H3K9me2 from
the human sample. A propionyl group (pr) is present on the N terminus and Lys-14. b and y type ions are labeled in E and F.
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FIGURE 4. Comparison of full mass spectra depicting H3K27 and Lys-36 modifications on the [M  2H]2 peptide spanning residues 27– 40 (KSAPA-
TGGVKKPHR) from human HEK cells (A), mouse MEF cells (B), Tet (C), and yeast (KSAPSTGGKKPHR) (D). E, MS/MS spectrum of the [M  2H]2 27– 40
peptide containing H3K36me3 from the yeast sample. Propionyl groups (pr) are present on the N terminus, Lys-27 and Lys-37. F, MS/MS spectrum of the [M 
2H]2 27– 40 peptide containing H3K27me3 from the human sample. Propionyl groups (pr) are present on the N terminus, Lys-36 and Lys-37. b and y type ions
are labeled in E and F. Ions arising from non-histone peptides or contamination are labeled with an asterisk.
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and functionally well characterized methylation modifications
among species (a summary is depicted in Fig. 5A, abundant
monomethyl  one red circle, dimethyl  two red circles, and
trimethyl  three red circles). Especially di- and trimethylation
of H3K4 and H3K36, as well as dimethylation of H3K79, have
been shown to be associated with gene activation (16), whereas
methylation of Lys-9 and Lys-27 on H3, especially di- and tri-
methylation, are found to be involved in transcriptional silenc-
ing (32). As depicted in Fig. 5A, H3 (H3.3) from yeast was
enriched in activation marks (light gray boxes). In contrast,
histone H3 (mixture of H3.1, H3.2, and H3.3) from both
mammals was enriched in silencing modifications (dark gray
boxes). Interestingly, we observed a pattern of abundantmethyl
marks on histone H3 (mixture of H3.2 and H3.3) from Tet that
shows characteristics from both yeast and mammals. Tet H3
had abundant K4me1, -me2, and -me3 (active marks), but also
K9me3 and to our surprise K27me1, -me2, and -me3; the latter
have not been described previously (see Table 1). These results
suggest that an evolutionary trend might exist from activation
toward silencing PTMs, which also correlates with the appear-
ance of different histone H3 variants.
To extend the analysis of abundant PTMs among different
species, we additionally used antibodies against the MS/MS-
detected abundant methyl marks (see Fig. 5A). Fig. 5B shows
the results of one representative (of three) “zoo-blot.” Histones
were acid-extracted and subjected to immunoblotting, and
recombinant H3 from Xenopus was used as a negative control.
We also included histones from Drosophila melanogaster (fly),
as an additionalmulticellular eukaryote that contains onlyH3.2
and H3.3, but not H3.1. With this immunobiochemical
method, we observed a similar pattern of abundant methyl
marks, as we have found by MS/MS. Significantly, H3K4me2
TABLE 1
Post-translational modifications of H3
Data obtained from comparative analysis experiments conducted with tandemmass spectrometer (linear quadrupole ion trap-Fourier transform) on one H3 sample (Tet)
and on two independent H3 samples isolated from yeast (S. cerevisiae), mouse (NIH3T3 and MRL-MPJ spleen cells) and human (HEK293) cells. All modifications were
localized by nano-liquid chromatography-MS/MS experiments.
Residue/peptide Modification Tet Yeast Mouse Human
TK4QTAR Monomethyl a   
Dimethyl   NDb ND
Trimethyl   ND ND
Acetylc L ND L 
K9STGGKAPR Monomethyl ND d  
Dimethyl ND ND  
Trimethyl  ND  
Acetyl  V L L
KSTGGK14APR Dimethyl ND L,V ND ND
Acetyl  V  
K9STGGK14APR Monomethyl  acetyl ND ND V 
Dimethyl  acetyl ND ND  
Trimethyl  acetyl ND ND  
Acetyl  acetyl  L  
K18QLATKAAR Monomethyl ND   
Acetyl    
KQLATK23AAR Monomethyl ND  V 
Acetyl    
K18QLATK23AAR Acetyl  acetyl    
K27SAPATGGVKKPHR Monomethyl d ND  
Dimethyl d ND  
Trimethyl d Ld  
Acetyl    L
KSAPATGGVK36KPHR Monomethyl    
Dimethyl ND   
Trimethyl ND  ND ND
Acetyl L L ND L
K27SAPATGGVK36KPHR Monomethyl  monomethyl ND ND  
Monomethyl  dimethyl ND ND  
Monomethyl  trimethyl ND ND ND 
Monomethyl  acetyl ND ND ND V
Dimethyl  monomethyl ND ND  
Dimethyl  dimethyl ND ND  
Trimethyl  monomethyl ND ND  
Trimethyl  dimethyl ND ND V 
Acetyl  dimethyl ND L ND ND
Acetyl  acetyl ND L ND ND
YQK56STELLIR Monomethyl  ND ND 
Trimethyl ND ND ND V
Acetyl   ND L
K64LPFQR Monomethyl ND ND ND 
Acetyl ND L ND ND
EIAQDFK79TDLR Monomethyl    
Dimethyl ND   
Trimethyl ND  ND ND
Acetyl ND ND ND L
VTIMPK122DIQLAR Monomethyl ND ND ND 
a, detected in both experiments; L, detected, but low abundance; and V, detected in only one experiment.
bND, not detected.
cNovel modifications are highlighted in bold letters.
dKnown modifications that were not detected previously in one organism.
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and H3K4me3, associated with transcriptional activation, were
very abundant inTet and yeastwhen comparedwithmouse and
human histone H3. Somewhat surprisingly, H3K4me2 and
H3K4me3 were not detected by MS/MS in mouse and human
samples but were observed by immunoblotting, albeit at a low
level when compared with Tet and yeast. In contrast to ourMS
analyses, we could not detect the H3K9me1 mark in yeast by
immunoblotting suggesting that this mark was either present
only at very low abundance or that
this modification could not be
detected with antibodies because of
detection or epitope occlusion
issues. In contrast, and in accord-
ance with our MS results, fly,
mouse, and human H3 contained
high levels of PTMs associated with
transcriptional silencing, such as
H3K9- and H3K27me1, -me2, and
-me3. In conclusion, most of the
data we obtained by MS/MS analy-
ses of histone H3 from different or-
ganisms could be reproduced by
immunobiochemical experiments
and strengthen our observation that
organisms differ in their histone H3
lysine methylation profiles dramati-
cally. In general, less complex
eukaryotes contain more marks
associated with transcriptional acti-
vation, whereas more complex
eukaryotes tend to have more mod-
ifications that are involved in gene
silencing.
Fig. 5C depicts some of the acety-
lation marks found on histone H3
among different species by MS/MS
(abundant acetyl mark  filled blue
circle, less abundant acetyl mark 
circle with blue dots). To further
evaluate the H3 acetylation data we
obtained by MS/MS, we performed
zoo-blots with antibodies against
some of these acetylation marks as
described in Fig. 5D. We developed
an antibody against the novel
H3K4ac mark that unfortunately
showed cross-reactivity against
H4K5ac (for the characterization of
this antibody see supplemental Fig.
S3). Nevertheless, our immunobio-
chemical analysis further supported
the observed acetylation pattern by
MS/MS. Interestingly, we again
noticed that unicellular eukaryotes
contained more acetylation marks
associated with gene transcription,
such as H3K9ac and H3K27ac,
whereas the novel H3K4ac was only
detected on human H3. It should be noted that some antibodies
(anti-H3K27me3, anti-H3K36me1, anti-K36me2, and anti-
K36me3) gave reproducibly varied results in these immunobio-
chemical analyses.
Novel PTMsandPTMPatterns onHistoneH3—Several novel
PTMswere identified byMS/MS, which are summarized in Fig.
6. Most of these novel PTMs were of low abundance and are
therefore depicted as dotted circles (blue  acetylation, and
FIGURE 5. A, comparison of abundant histone H3 methylation modifications at Lys-4, Lys-9, Lys-27, Lys-36, and
Lys-79 from human, mouse, Tet, and yeast. H3 from human and mouse is highly modified at Lys-9, whereas Tet
and yeast are more highly modified at Lys-4. Tet is hypomodified at Lys-79, whereas yeast is the only species to
contain Lys-79 trimethylation and no Lys-27 modifications. B, immunoblots with acid-extracted histones from
different species as marked above and several antibodies as described on the left side are shown. 1 g of
recombinant histone H3 from Xenopus (H3.2) was used as negative control (right lane). Staining of these blots
with Ponceau was performed to ensure equal loading (blot below). Modifications that have been associated
with transcriptional activation are boxed in light gray, and modifications that are associated with transcriptional
silencing are shown in dark gray boxes. C, comparison of histone H3 acetylation modifications at Lys-4, Lys-9,
Lys-27, Lys-36 (52), Lys-56, and Lys-79 from human, mouse, Tet, and yeast (filled blue circle, abundant acetyl
marks; circle with blue dots, not abundant acetyl marks). D, immunoblots stripped from B were used for analysis
of acetylation profile among species.
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redmethylation) and include the identification of the follow-
ing acetylation marks: H3K4ac in all organisms except yeast,
with the strongest signal in humans and H3K79ac only in
humans. In addition to these results, the companion report (52)
shows the existence ofH3K36 acetylation aswell. Supplemental
Fig. S2 shows the MS/MS spectra of a peptide containing
H3K4ac. These novel acetylation marks are particularly inter-
esting, because they occur on lysine residues, which, when
methylated, are associated with transcriptional activation. A
differential read-out between methylation and acetylation of
the same residue often results in a functional “switch” between
transcriptional activation or silencing, as has been described for
H3K9 and H3K27 (33). Our observation that H3K4 and H3K79
residues can also be acetylated at very low abundances might
suggest that these acetylation marks counteract methylation of
these residues leading to altered states of gene expression or
participation in other downstream processes that remain
poorly appreciated and poorly understood.
In addition to the novel acetylation marks mentioned above,
we also identified novel methylation marks on H3:
K9me1K14me2 (supplemental data page 3), and K27me3
(supplemental data page 24) in yeast, K27me1, -me2, and -me3
in Tet (supplemental data pages 21–23), and K56me3 in
humans (supplemental data page 5). All these marks, except
Lys-27methylation in Tet, were at a very low occupancy, which
might explain why these PTMs have not been identified
previously.
Next the methylation and acetylation patterns were com-
pared among the selected species. As depicted in Fig. 6, many
differences between PTM patterns exist among species. Inter-
estingly, most lysine residues in humans can be either methyl-
ated or acetylated, with exceptions
being H3K14, H3K64, and H3K122.
Because it is possible that modifica-
tionsmight act together to achieve a
particular biological outcome, we
sought to identify PTM patterns on
H3 peptides that contained more
than one modifiable residue. PTMs
that co-exist on the same peptide
are schematically shown in Fig. 6 by
line connections. This scheme shows
that the complexity of PTM pat-
terns on histone H3 increases from
unicellular eukaryotes to mammals.
Modest differences between mouse
and human H3 PTM patterns may
reflect subtle differences in epige-
netic signatures in mice that are not
always mirrored in humans.
Comparison of PTMs on Histone
H4 among Unicellular Eukaryotes
and Mammals—Because our stud-
ies showed that species differ in
their PTMs and PTM pattern for
histone H3, we wondered if this was
the result of the development ofmore
enzymes that “write” and proteins
that “read” these marks and/or the difference between the num-
bersof functionally distincthistoneH3variants amongorganisms.
To investigatewhichof thesepossibilitiesoracombinationofboth
may be correct, we turned our attention to histone H4. H4 was
selected in part, because it is the only histone protein of which no
other histone variants have been identified in these organisms.
HistoneH4 is highly conserved in its amino acid sequence among
species (supplemental Fig. S4A) and similar to other species as
compared by sequence identity analysis (supplemental Fig. S4B).
As described above for histone H3, we subjected RP-HPLC-
purified histone H4 from the four different organisms to
MS/MS analysis following propionylation and trypsin diges-
tion. Fig. 7 displays the summed full mass spectra around the
745–780m/z range (for human (A), mouse (B), and yeast (D)),
which show the [M  2H]2 peptides spanning residues 4–17
and the 840–872 range for Tet (C) (peptide-spanning residues
1–16). The peptide-spanning residues 4–17 (1–16Tet) contain
four acetylation sites (Lys-5, Lys-8, Lys-12, and Lys-16 in
human, mouse, and yeast, and Lys-4, Lys-7, Lys-11, and Lys-15
in Tet). As seen in Fig. 7A, the most abundant form of the 4–17
peptide for the human H4 is the unmodified form, followed by
the one acetyl form, then two, three, and four acetyl forms.
Remarkably, a very similar pattern of acetyl PTMs can also be
observed on H4 from the other species (Fig. 7, B–D). Fig. 7E
displays a tandemMS of the human sample seen in Fig. 7A. The
fragment b and y ions show that all lysine residues on this 4–17
peptide are acetylated. MS/MS experiments also determined
that the major pattern of acetylation on human, mouse, and
yeast H4 peptides essentially followed the trend that mono-
acetylation is mainly at Lys-16, di-acetylation mainly at Lys-16
and Lys-12, tri-acetylation at Lys-16, Lys-12, and Lys-8 or
FIGURE 6. Summary of histone H3 modifications detected in MS/MS experiments from human, mouse, Tet,
and yeast. Methyl marks are depicted as red circles (one circle, mono-methyl; two circles, di-methyl; and three circles,
tri-methyl), and acetylation marks are depicted as blue circles. Colored circles represent abundant marks, whereas
dotted circles show modifications that are present in low abundance or that have been detected in only one of the
two runs. Novel modifications are in yellow boxes, and modifications, which have not been described previously for
a specific organism, but are otherwise known, are surrounded by green boxes.
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Lys-5, and tetra-acetylation at Lys-16, Lys-12, Lys-8, and Lys-5
(supplemental data pages 29–31), although other lower level
combinations exist. This pattern has been previously reported
and termed the “zipper acetylation” motif (34). Overall acetyla-
tion levels of histone H4 fromTet were similar to other species,
but higher abundant different combinations of acetylationwere
also detected as shown in Fig. 7F with a tri-acetylated 1–16
peptide containing acetyl marks at Lys-4, Lys-7, and Lys-11 as
revealed by the numerous b and y type fragment ions and
shown in supplemental data pages 32–34 (Tet also contains no
N-terminal acetylation, which is different from all other orga-
nisms). A similar methylation pattern was observed on H4K20
as was seen on H3K9, because human and mouse contained
much higher amounts of this repressive mark (especially di-
methylation) than yeast and Tet, which were mostly unmodi-
fied (supplemental Fig. S5). The results of our tandem MS
experiments are summarized in Table 2 and are depicted in Fig.
8.Novel histoneH4modification sites such asH4K20ac in yeast
and others are also displayed as supplemental data pages 25–28.
The lower number of PTMs and the consistency observed in
the acetylation patterns of H4 was not seen in our analysis of
H3, suggesting that histone H3 displays more organismal dif-
ferences (“epigenetic signatures”) than its dimeric partner H4.
DISCUSSION
Many studies to date have analyzed PTMs of histones, in
particular H3, in different organisms by separate techniques.
Although these studies enriched and promoted the under-
standing of the function of histone marks in biological path-
ways, to our knowledge, few analyses have sought to provide a
systematic comparison of histone H3 and H4 PTMs among
different model organisms. Several conclusions can be drawn
from our study: 1) Overall, the H3 PTM profile among unicel-
lular eukaryotes and mammals differs significantly, and the
PTM patterns become more complex from “simple” to more
“complex” eukaryotes. 2) With few exceptions, most lysines in
H3 show the general tendency to be eithermethylated or acety-
lated although to varying extents depending upon site and or-
ganism. The significance of extremely low levels of one or the
other of these modifications remains unclear. The argument
that low levels of PTM reflect physiologically irrelevant “noise”
that is detected by high sensitivity methods, cannot be ruled
out. 3) Unicellular eukaryotes, notably yeast and Tet, exhibit
more modifications associated with transcriptional activation,
whereasmammals havemoremarks involved in gene silencing.
This observation mirrors the studies that show that the major-
ity of the genome in unicellular eukaryotes is transcriptionally
competent, whereas 60% of the mammalian genome is per-
manently silenced, and only3%of its DNAencodes structural
genes (reviewed in Ref. 35). 4) Surprisingly, we identified byMS
what appear to be species-specific PTMs such as: H3K14me2
(yeast), H3K56me3 (human), H3K64me1 (human), H3K64ac
(yeast), H3K79me3 (yeast), H4K20ac (yeast), H3K79ac
(human), and H3K122me1 (human). 5) We also found novel
modifications: H3K4ac (human, and to a lesser extent, mouse,
and Tet), H3K56me3 (human), H3K64ac (yeast), H4K20ac
(yeast), and H3K79ac (human). Collectively, these data argue
against there being a universal histone code and underscore the
need to avoid general conclusions obtained from one organism.
One important difference between budding yeast and other
eukaryotes is that, although it contains well defined “silenced”
chromatin (36), several hallmark features of constitutive het-
erochromatin found inmore complex eukaryotes (e.g. the pres-
ence of HP1 that has been shown to specifically bind to
H3K9me2 and -me3 with its chromodomain (37–39)) have yet
to be observed (40). This finding correlates well with the pres-
ence of only an “active” H3.3 variant in yeast. On the other
hand, Tet has been reported to contain H3K9 methylation and
the expression of an HP1-like binding protein (Pdd1p) (41, 42).
FIGURE 7. Comparison of full mass spectra depicting histone H4 acetylation modifications on the [M  2H]2 peptide spanning residues 4 –17
(GKGGKGLGKGGAKR) from human HEK cells (A), mouse MEF cells (B), Tet (1–16 residue peptide (C), AGGKGGKGMGKVGAKR), and yeast (D). E, MS/MS
spectrum of the [M  2H]2 4 –17 peptide of H4 containing tetra-acetylation at Lys-5, Lys-8, Lys-12, and Lys-16 from the human sample. A propionyl group (pr)
is present on the N terminus. F, MS/MS spectrum of the [M  2H]2 1–16 peptide of H4 containing acetylation at Lys-4, Lys-7, and Lys-11 from the Tet sample.
Propionyl groups (pr) are present on the N terminus and on Lys-15. b and y type ions are labeled in E and F. Asterisks, ions that indicate that an isomeric peptide
containing three acetyl groups at different residues is also present.
TABLE 2
Post-translational modifications of H4
Data obtained from comparative analysis experiments conducted with tandemmass spectrometer (linear quadrupole ion trap-Fourier transform) on one H4 sample (Tet,
yeast, mouse (NIH3T3 and MRL-MPJ), spleen cells, and human HEK293 cells). All modifications were localized by nano-liquid chromatography-MS/MS experiments.
Residue/peptide Modification Tet Yeast Mouse Human
GK5GGK8GLGK12GGAK16R 1 Acetyl (mostly Lys-16) a   
2 Acetyl (mostly Lys-16 and Lys-12)    
3 Acetyl (mostly Lys-16, Lys-12, and Lys-8)    
4 Acetyl (Lys-16, Lys-12, Lys-8, and Lys-5)    
K20VLR Monomethyl NDb c  
Dimethyl ND c  
Trimethyl ND ND  
Acetyld ND c ND ND
DNIQGITK31PAIR Monomethyl ND   
Dimethyl ND ND ND ND
Trimethyl ND ND ND ND
Acetyl ND ND  
a, detected.
bND, not detected.
cKnown modifications that were not detected previously in one organism.
dNovel modifications are highlighted in bold letters.
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Interestingly, this organism contains in addition to H3.3
another H3 variant (H3.2), suggesting that there might be cor-
relations between the occurrence of heterochromatin and spe-
cific H3 variants each decorated with PTM signatures. The
finding of H3K9me1 and H4K20me2 in budding yeast was
unexpected, given the absence of knownwriters and readers for
this mark in this organism.Whether novel enzyme and effector
systems exist or whether certain known activities are simply
more promiscuous in yeast due to differences in gene regula-
tion or nuclear architecture as compared with other organisms
is not known. Similarly, the amino acid sequence adjacent to
H3K79 is not conserved in Tet (see supplemental Fig. S1A), and
additionally, a Dot1 homologue, the enzyme that methylates
H3K79 (29) is not found in Tet.11 It will be of interest to identify
the enzyme responsible for H3K79me1 in Tet.
A different picture emerged from our data about lysinemod-
ifications and their pattern on histone H4 among organisms.
Notably, the H4 PTM profile and pattern are not as complex as
those shown for histone H3 among species. Although we also
identified novel marks on H4 (H4K20Me2 and H4K20ac in
yeast, H4K31me1 in all organisms examined except yeast, and
H4K31ac inmouse and humans), the number of PTMs is much
lower for H4 than H3.
This may indicate that a combination of two different mech-
anisms has evolved. We suggest that, not only have more
enzymes that set these marks (“writers”) and proteins that spe-
cifically bind to these modifications (“readers”) evolved during
evolution, but also the emergence of more functionally distinct
histoneH3 variantsmay play a role in the here observed mod-
ification differences among organisms (reviewed in Ref. 43).
It has been shown that more histone-modifying enzymes and
proteins that recognize these marks have evolved over time
(reviewed in Ref. 44). For example, the number of genes
encoding for SET domain-containing proteins differs greatly
among different species. It has been estimated that the
human and mouse genomes each encode 50 predicted SET
domain proteins (45), whereas Schizosaccharomyces pombe
contains only 10 putative SET domain histone methyl-
transferases, and S. cerevisiae has no more than 7 (27). On
the other hand, besides an increase in the number of genes
encoding histone-modifying proteins, there has also been a
shift in the number of histone variants during the evolution
from unicellular toward multicellular eukaryotes. Over the
last several years, many studies have shown that variants
from different histone families, most prominently the family
of H2A histones, play distinct roles in diverse biological pro-
cesses (reviewed in Refs. 46 and 47).
Interestingly, even though in contrast toH2Avariants, which
differ greatly in their primary sequence, H3 variants contain
only small amino acid changes between each other, and their
function might also be separate. The H3.3 variant, expressed
replication independently, has been shown to be associated
with transcriptional activation by its specific PTM profile (18,
19, 48) and biochemical experiments, such as chromatin immu-11 Y. Liu, personal communication.
FIGURE 8. Summary of histone H4 modifications detected by MS/MS from human, mouse, Tet, and yeast samples. Methyl marks are depicted as red circles (one
circle, me1; two circles, me2; and three circles, me3) and acetylation marks are depicted as blue circles. Colored circles represent abundant marks, whereas dotted circles
show modifications that are present in low abundance or which have been detected in only one of the two runs. Novel modifications are in yellow boxes.
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noprecipitation and chromatin immunoprecipitation-chip
assays (49–51). Another study inArabidopsis thaliana showed
that H3.2 contains amodification profile linking it to transcrip-
tional repression (48). Previously, we showed by quantitative
MS/MS analyses that, not only H3.2, but also the mammalian-
specific H3.1 variant, have modifications associated with gene
repression, but that these variants are enriched in different
“silencing” PTMs, suggesting that these highly similar H3 vari-
ants might have separate biological functions (19).
In summary, our data suggest that, during evolution, in addi-
tion to the emergence of more histone-modifying enzymes, the
appearance of more histone H3 PTMs and H3 variants led to a
more complex and diverse histone code over time (47–49).
Taken together, our findings underscore the need to use mul-
tiple approaches to identify PTMswith confidence, particularly
those that occur at low levels.
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